Body Mass Index, Lipid Metabolism and Estrogens: Their Impact on Coronary Heart Disease

被引:21
作者
Kolovou, G. D. [1 ]
Kolovou, V. [1 ]
Kostakou, P. M. [2 ]
Mavrogeni, S. [1 ]
机构
[1] Onassis Cardiac Surg Ctr, Cardiol Dept 1, Athens 17674, Greece
[2] Thriassio Hosp, Dept Cardiol, Athens, Greece
关键词
Body fat; coronary heart disease; estrogens; hormone replacement therapy; lipids; menopause; HORMONE REPLACEMENT THERAPY; ENDOGENOUS POSTMENOPAUSAL HORMONES; DENSITY-LIPOPROTEIN RECEPTOR; GENDER-RELATED DIFFERENCES; CARDIOVASCULAR-DISEASE; POSTPRANDIAL LIPEMIA; ATHEROSCLEROSIS RISK; ADIPOSE-TISSUE; SECONDARY PREVENTION; CLINICAL-RELEVANCE;
D O I
10.2174/0929867321666140901114515
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Estrogens influence lipid metabolism and body fat distribution in women. Premenopausal women have increased lipoprotein lipase action in abdominal and femoral subcutaneous fat compared with men of the same age. Estrogens may also affect adipose tissue either directly through specific estrogen receptors or indirectly via their effects on other tissues. As adipose tissue produces several cytokines including leptin, adiponectin and interleukin-6, estrogens may alter their levels, thus influencing various biological processes. Lack of estrogens such as in menopause, causes an increase in visceral adiposity, leading to changes in lipid and lipoprotein metabolism. Due to those alterations, postmenopausal women are more prone to coronary heart disease. In this review the influence of estrogens on body mass index, lipid metabolism and some of the therapeutic options will be analyzed.
引用
收藏
页码:3455 / 3465
页数:11
相关论文
共 145 条
  • [1] Adipocytokine profile of type 2 diabetics in metabolic syndrome as defined by various criteria
    Al-Daghri, Nasser M.
    Al-Attas, Omar S.
    Al-Rubeaan, Khalid
    Sallam, Reem
    [J]. DIABETES-METABOLISM RESEARCH AND REVIEWS, 2008, 24 (01) : 52 - 58
  • [2] Severity of cardiovascular disease in postmenopausal women:: associations with common estrogen receptor α polymorphic variants
    Alevizaki, M.
    Saltiki, K.
    Cimponeriu, A.
    Kanakakis, I.
    Xita, N.
    Alevizaki, C. C.
    Georgiou, I.
    Sarika, H-L
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2007, 156 (04) : 489 - 496
  • [3] HEPATIC CHOLESTEROL-METABOLISM IN ESTROGEN-TREATED MEN
    ANGELIN, B
    OLIVECRONA, H
    REIHNER, E
    RUDLING, M
    STAHLBERG, D
    ERIKSSON, M
    EWERTH, S
    HENRIKSSON, P
    EINARSSON, K
    [J]. GASTROENTEROLOGY, 1992, 103 (05) : 1657 - 1663
  • [4] Cholesterol and atherosclerosis: modulation by oestrogen
    Barton, Matthias
    [J]. CURRENT OPINION IN LIPIDOLOGY, 2013, 24 (03) : 214 - 220
  • [5] The adipocyte-secreted protein Acrp30 enhances hepatic insulin action
    Berg, AH
    Combs, TP
    Du, XL
    Brownlee, M
    Scherer, PE
    [J]. NATURE MEDICINE, 2001, 7 (08) : 947 - 953
  • [6] Bessesen DH, 1998, SEMIN ONCOL, V25, P28
  • [7] Hormone replacement therapy and stroke
    Billeci, Antonia M. R.
    Paciaroni, Maurizio
    Caso, Valeria
    Agnelli, Giancarlo
    [J]. CURRENT VASCULAR PHARMACOLOGY, 2008, 6 (02) : 112 - 123
  • [8] Predictors of diet quality among overweight and obese postmenopausal women
    Boynton, Alanna
    Neuhouser, Marian L.
    Sorensen, Bess
    McTiernan, Anne
    Ulrich, Cornelia M.
    [J]. JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION, 2008, 108 (01) : 125 - 130
  • [9] Britton K.A., 2013, J AM COLL CARDIOL, V1, pS0735
  • [10] Leptin as Clinical Target
    Cai, Chunlin
    Shi, Fu-Dong
    Matarese, Giuseppe
    La Cava, Antonio
    [J]. RECENT PATENTS ON INFLAMMATION & ALLERGY DRUG DISCOVERY, 2009, 3 (03) : 160 - 166